Mainland China and overseas wealth, alongside family offices, is driving insurance demand in the city to new highs.
SVB UK – now HSBC Innovation Banking – launches in Hong Kong
HSBC announced today it has officially launched HSBC Innovation Banking in Hong Kong, delivering a globally connected and specialised proposition for venture-backed businesses and their investors.
UOB targets fivefold growth in Hong Kong private bank AUM by 2030
It also plans to treble its client adviser ranks to about 60, as the Singapore lender seeks to capture rising wealth flows between China and Asean Read more at The Business Times.
HSBC summit turns future trends into wealth strategies
Premier Elite customers gain access to wealth solutions spanning unit trusts, structured products, bonds, securities, ETFs, and margin trading ...
Malaysia, Hong Kong securities regulators agree to ease dual IPO listings, strengthen collaboration
KUALA LUMPUR, July 23 (Reuters) - Malaysian and Hong Kong securities regulators signed a memorandum of understanding on Thursday aimed at facilitating dual initial public offering (IPO) listings in ...
Hong Kong-listed Get Nice hit by cyberattack, impacting trading systems
July 22 (Reuters) - Hong Kong-listed Get Nice Holdings said on Wednesday that its units were hit by a cyberattack on July 19, temporarily affecting its electronic trading systems and other services, ...
China’s moonshot AI bets on Kimi K3 momentum, eyes $50 billion valuation ahead of Hong Kong IPO: report
Moonshot AI is reportedly beginning discussions on a final round of fundraising in August, before listing in Hong Kong, at a valuation of nearly $50 billion. The Chinese AI lab is likely to close a ...
HSBC appoints cross-bank leaders after Hang Seng privatisation, source says
HSBC has appointed cross-bank leaders to oversee seven corporate functions it has in common with Hang Seng Bank, which it took private last year, according to a source familiar with the matter, in ...
Wall Street can wait: Why one US biotech firm is listing in Hong Kong first
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
Wahaha Heiress Loses Hong Kong Appeal Over Freeze on $1.8 Billion HSBC Account
The Hong Kong High Court upheld an asset preservation order sought by three of the late founder Zong Qinghou’s children, ensuring the funds remain secured for an ongoing lawsuit in Hangzhou ...
China’s Zhongji Innolight plans $8 billion Hong Kong IPO, sources say
By Kane Wu, Selena Li and Yantoultra Ngui HONG KONG, July 21 (Reuters) - China's Zhongji Innolight, a maker of optical transceivers, will launch a Hong Kong listing on Wednesday to raise at least $8 ...
Hong Kong Court Rejects Water Heiress Appeal Over $1.8 Billion
A Hong Kong court has dismissed a further appeal by the heiress to Hangzhou Wahaha Group Co., preserving two prior orders involving $1.8 billion in assets held in an HSBC Holdings Plc account.
Hong Kong’s HKDAP stablecoin could launch this month
A Hong Kong dollar stablecoin backed by a Standard Chartered-led venture could begin trading as early as July 31, 2026, offering the crypto market a regulated digital currency pegged to something ...
Hong Kong can serve as a ‘launch pad’ for AI firms, finance chief Paul Chan says
Comments follow call by President Xi Jinping for AI to become a key driving force for all countries to promote shared prosperity.